Long-Term Safety and Effectiveness of Canakinumab in Patients with MKD/HIDS: Interim Analysis of the RELIANCE Registry

Long-Term Safety and Effectiveness of Canakinumab in Patients with MKD/HIDS: Interim Analysis of the RELIANCE Registry

Abstract Introduction Interim analysis of the long-term safety and effectiveness of canakinumab, at a patient level, in the mevalonate kinase deficiency/hyperimmunoglobulin-D syndrome (MKD/HIDS) cohort of the RELIANCE registry. Methods From June 2018, the RELIANCE registry enrolled paediatric (aged ...

Full description

Saved in:
Bibliographic Details
Main Authors: Prasad T. Oommen, Tilmann Kallinich, Juergen Rech, Norbert Blank, Julia Weber-Arden, Jasmin B. Kuemmerle-Deschner
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-12-01
Series:Rheumatology and Therapy
Subjects:
Canakinumab
Fever syndromes
Hyperimmunoglobulin-d syndrome
Autoinflammatory disease
Mevalonate kinase deficiency
Online Access:https://doi.org/10.1007/s40744-024-00733-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items